Follow
Journal of Molecular Cancer
Title
Cited by
Cited by
Year
Complete pathological remission after treatment with olaparib in a patient with PTEN-deficient sarcomatoid prostate cancer
J Wang
Journal of Molecular Cancer 1 (3), 2, 2018
52018
The arrow of carcinogenesis
SG Grant
Journal of Molecular Cancer 1 (1), 6, 2017
4*2017
A Medical Nutritional Supplement Improves BMI, Hemoglobin, Fatigue levels in female anemic patients
C Mehndiratta
Journal of Molecular Cancer 4 (3), 1, 2021
2021
Diabetes in pregnancy and Diabetes in children
B Hira
Journal of Molecular Cancer 4 (3), 1, 2021
2021
OBESITY: A THREAT TO GENERATIONS
H BHARDWAJ
Journal of Molecular Cancer 4 (3), 1, 2021
2021
Impact of Social Determinants of Health (SOC) on Prevalence of Caesarean Section among women with Gestational Diabetes Mellitus (GDM) in the United States
O Akinyemi
Journal of Molecular Cancer 4 (3), 1, 2021
2021
Neurological and Molecular Mechanism of Diabetic Neuropathy
K Alare
Journal of Molecular Cancer 4 (3), 1, 2021
2021
The Role of Mutations in BRCA1 BRCA2 and Other Factors Involved in Homologous Recombination in Cancer Development and Treatment PARP Inhibitors and Beyond
O Dasgupta
Journal of Molecular Cancer 4 (2), 1, 2021
2021
Effectiveness of second and third generation TKIs (Dasatinib, Nilotinib and Ponatinib) in Chronic Myeloid Leukemia Treatment
MK Panigrahi
Journal of Molecular Cancer 4 (2), 1, 2021
2021
LncRNA as a Therapeutic Target for Angiogenesis
J Wang
Journal of Molecular Cancer 4 (2), 1, 2021
2021
Discovery and pharmacological characterization of OMO-1, a potent, highly selective and orally bioavailable MET kinase inhibitor
TPS Perera
Journal of Molecular Cancer 4 (2), 1, 2021
2021
Does the coronavirus spread through food
RZ Arslaan
Journal of Molecular Cancer 4 (1), 1, 2021
2021
Medical Nutritional Supplement Improve Glycemic Control in Pre-Diabetics and Type 2 Diabetics: A Prospective Study in Indian Population
P Srivastava
Journal of Molecular Cancer 4 (1), 1, 2021
2021
Type 2 diabetes and heart failure
J Trokis
Journal of Molecular Cancer 4 (1), 1, 2021
2021
GLUCAGON LIKE PEPTIDE AGONIST AND CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES
G DIEUZEIDE
Journal of Molecular Cancer 4 (1), 1, 2021
2021
Targeting mithocondrial morphodinamics
D Molino
Journal of Molecular Cancer 4 (1), 1, 2021
2021
Pathologic exam of a biopsy
B Mathon*
J Mol Cancer 4 (4), 2021
2021
Oncology & Radiology 2018- Cancer Awareness and Survival
W Tibairira
Journal of Molecular Cancer 3 (2), 1, 2020
2020
Cancer Oncology 2018: Cerebral aneurysms mechanisms
S Bu-Yiang
Journal of Molecular Cancer 3 (2), 1, 2020
2020
Oncology & Radiology 2018: Finding substance molecule to immune stop blockade that enhances the medical care for hepatocarcinoma
KM Yoon
Journal of Molecular Cancer 3 (2), 1, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20